Delivery Order SPE2DB22D3301-SPE2DB24FY9PS

Award Date 6/28/24
Potential Completion Date 7/1/24
Potential Value $6.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Trelegy Ellipta pharmaceutical products, valued at $2,680.83. The award was made by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. This is a delivery order contract with a firm-fixed price pricing type. The contract has a completion date of June 18, 2024 and was...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $1,251.29 for the supply of the pharmaceutical product Trelegy Ellipta 200-62.5-25 60s. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of June 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product Trelegy Ellipta 100-62.5-25 28S. The $2,255.76 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Trelegy Ellipta 200-62.5-25 60S pharmaceutical product to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $4,327.89, has an ultimate completion date of April 23, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division was made by the Defense Logistics Agency (DLA) Troop Support Medical. The $44,235.45 firm fixed price delivery order is for the pharmaceutical product Trelegy Ellipta 200-62.5-25 60s. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, under which Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $27,156.55 to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the supply of Trelegy Ellipta 100-62.5-25 60s, a prescription medication, with a performance period through April 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with DLA Troop Support Medical, which serves as...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The $7,146.22 firm fixed price Delivery Order contract has a completion date of September 7, 2022 and was awarded on September 6, 2022 by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,438.93 firm fixed price delivery order is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60s. The contract has an ultimate completion date of July 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $3,922.75 for the supply of Trelegy Ellipta 100-62.5-25 60S medication. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 1, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a delivery order (SPE2DB20D3103|SPE2DB25FM5Z5) valued at $1,967.67. The contract is with the Defense Logistics Agency (DLA), a defense agency, to provide the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. The contract has an ultimate completion date of February 6, 2025 and is a firm fixed price arrangement. Amerisourcebergen holds a significant...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY9PS
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of pharmaceutical products, including the medication Trelegy Ellipta 200-62.5-25 60S, to the Defense Logistics Agency (DLA). The $6,706.77 Delivery Order contract has a firm fixed-price pricing type and a completion date of July 1, 2024.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award does not have a set-aside designation.

Generated 9/27/24, 9:27 AM